BioLife Expects QR Stop-Bleeding Products To Dramatically Boost Revenues
This article was originally published in The Tan Sheet
BioLife believes it can reach $5 mil. in FY 2003 sales driven by increased revenues from its UrgentQR stop-bleeding product and other similar offerings in the scab-forming powder line
You may also be interested in...
Band-Aid Liquid Bandage is reaching food, drug and mass shelves now after shipping in late February, according to Johnson & Johnson Consumer Products
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning